Neuroendocrine systems play a key role not only in the maintenance of whole-body homeostasis but also as the link between behavioural, endocrine and autonomic responses to environmental stimuli. It is becoming increasingly clear that neuroendocrine regulatory mechanisms are under the control of a combination of factors including genetic background, environment and early-life programming. Patterns of gene expression are increasingly being used to provide information on the genotypes associated with particular behaviours, and modulation of speci®c parts of the genome allow investigation of the contribution of particular genes. The sequencing of the genome provides a unique opportunity to elucidate the genetic contribution to neuroendocrine and behavioural processes, and to investigate the interactions between genetic and environmental factors. Although drugs can be used to activate or inhibit neurotransmitters and receptors, they lack speci®city. New technologies now permit the activation or inactivation of both neurotransmitters and receptors in speci®c areas of the brain for de®ned periods, including crucially important developmental windows when activation appears to have long-term consequences. The future challenges are to de®ne the critical mechanisms through which the genetic constitution of an individual human or experimental animal interacts with environmental cues to result in altered physiological or even pathological behaviour and endocrine function.
Introduction
An important objective for biomedical science over the past decade has been to resolve the genome that constitutes the fundamental basis of all processes of life. The completion of the sequencing of the human genome and the identi®cation of the full spectrum of potential genes now offers opportunities, both for elucidating the genomic mechanisms that drive physiological and behavioural processes and also for understanding how genomic variability and dysregulation contribute to individuality and pathology. In the postgenome era of the early 21st century the major challenge will be how to apply this genomic information to derive meaningful relationships between these processes. In the context of whole-animal function, the regulation of individual genes and animal behaviour can be considered the two ends of a reductionist±holistic spectrum, with behaviour arising from the complex interactions and integration between a wide range of processes acting at the molecular, cellular and physiological levels. For this reason establishing the associations between genomic processes and behaviour possibly offers one of the greatest challenges today. The pivotal role of the neuroendocrine system in regulating physiology and behaviour offers clear opportunities for unravelling these complex relationships.
Neuroendocrine signalling: a target for and regulator of gene expression patterns Neuroendocrine systems play a key role, not only in the maintenance of whole body homeostasis but also as the link between behavioural, endocrine and autonomic responses to environmental stimuli. Whilst the autonomic nervous system provides a rapidly responding signalling system with particular importance for the cardiovascular system, hormones provide the major signalling mechanism that has access to diverse systems of the body. Furthermore, as the various functions of each hormone have been identi®ed, it has become increasingly apparent that each hormone is associated with a spectrum of related actions. For example, oxytocin has major effects on uterine contraction associated with birth and on contraction of the mammary myoepithelium regulating milk release during lactation, but at the same time has powerful effects controlling af®liative/ maternal behaviours that are important for social bonding and the care of the offspring. Oxytocin has therefore been considered the peptide of motherhood (Insel et al., 1997) . This ability of one chemical signal to simultaneously regulate peripheral physiological processes and brain activity controlling complex behaviours has evolved from the physicochemical properties of peptides that are unable to cross the blood±brain barrier and are thus able to independently (but co-ordinatedly) control the two compartments. This property has been fully exploited to the point that nearly every hormone identi®ed in the periphery has also been detected in the brain, where it participates in neurotransmission. Indeed, when considering the neuroendocrine±behaviour interface, the boundaries of what can be considered neuroendocrinology and what is considered neurotransmission become vague and hard to justify. There is little distinction between the neuroendocrine signalling to the body and the signalling within the brain and, while it is debatable whether peptides ®rst evolved as hormones or transmitters, what is clear is that they pre-date the`classical' transmitters (amino acids, monoamines, acetylcholine) as neural signalling molecules.
The principal distinction between the neurotransmission mediated via peptides and that mediated via classical transmitters relates more to the spatial and temporal characteristics of the signal. The function of peptides is analogous to that of a hormone in the brain, in as much as the chemical signal is often distributed across a wide range of targets. Various terms have been applied to this mode of transmission, such as`volume transmission' and`neuromodulation'. This widespread signal distribution is achieved not only because peptides persist in the extracellular¯uid for long periods of time and are thus able to diffuse considerable distances but also because release occurs not only at specialized synapses but also across the whole neuronal surface with major physiological roles described for both axonal and dendritic release. From this diffuse signal the speci®city of action is achieved primarily through the expression of receptors in the target neurons, and in this regard the genomic mechanisms that regulate the cellular selectivity and magnitude of receptor expression are paramount. An example of this relationship is exempli®ed by the speciesspeci®c af®liative behaviours of montane and prairie voles which are closely correlated with the differential regional expression of vasopressin V 1a receptors in the brain (Insel et al., 1994) . Promoter sequences from the V 1a receptor gene of the two species differ, providing a potential mechanism for species-speci®c patterns of receptor expression. Indeed, mice which are transgenic for the prairie vole receptor gene with its promoter adopt both a neuroanatomical pattern of receptor expression and a behavioural response to vasopressin similar to that of the prairie vole (Young et al., 1999) . Thus, subtle variations in the promoter sequence or other components of the transcriptional machinery of receptor genes can alter the pattern of receptor distribution in the brain with consequent changes in physiological and behavioural responses to the endogenous neuropeptide.
Among the major transcriptional regulators, the receptors for steroid and thyroid hormones are critical. A very high proportion of genes have been shown to possess one or more putative steroid or thyroid response elements in their promoter and, as such, are potentially subject to regulation by the endocrine system. The ability of lipophyllic steroid/thyroid hormones to access all tissues of the brain and body places great importance on the cell-speci®c expression of receptors and the presence of the appropriate chaperones and response elements in determining their functional effectiveness. Furthermore, it is becoming increasingly apparent that steroid/thyroid hormones must run a gauntlet of factors to gain access to the cytosolic receptor. For example, the presence of steroid-binding proteins can regulate cellular access (e.g. a-fetoprotein expression in the brain of the neonatal female determines the access of oestrogen to areas of the brain undergoing sexual differentiation), while metabolizing enzymes serve to either generate biologically active steroids (e.g. aromatase or 5a-reductase will, respectively, generate the active metabolites estradiol or dehydrotesterone from testosterone) (McEwen & Alves, 1999) or convert steroids to their inactive forms (e.g. 11b-hydroxysteroid dehydrogenase type-2 will convert the neuroactive cortisol/corticosterone to the inactive 11-keto steroids cortisone/11-dehydrocorticosterone and thereby limit steroid access to the glucocorticoid receptors) (Seckl, 2001) . The functional activation/ repression of genes is subject not only to numerous constraints of ligand-receptor binding to response elements, but also to the combinatorial effects of multiple simultaneous transcriptional regulators, acting according to rules that still need to be elucidated.
Establishing the genomic basis for behavioural neuroendocrinology
From the approaches described above it has been possible to establish the relationships that exist between the expression and functional effects of speci®c hormones and the generation of speci®c physiological and behavioural effects and, conversely, to demonstrate the role that hormones have on the expression of particular genes. What may be concluded from this is that particular behavioural repertoires are associated with speci®c genetic signatures. For example, oestrogen-induced lordosis behaviour has been associated with increased hypothalamic expression of several genes that encode neurotransmitters and receptors which promote sexual activity [e.g. gonadotrophin releasing hormone (GnRH), oxytocin, and enkephalin, as well as a 1A -adrenergic, muscarinic and progesterone receptors] and it is the combined activation of these genes that is necessary to generate the full behaviour (Pfaff et al., 2000) . To date, studies of these associations have largely focused on a small number of genes with well-established behavioural roles, with the result that the genetic signature is far from complete. Indeed, it seems likely that > 99% of the neuroendocrine literature is based on an analysis of < 1% of the genome. However, emerging genomic technology and the sequencing of the entire genome offer the potential for a more comprehensive study of the gene±neuroendocrine±behaviour axis. This technology can be applied in two main directions. Firstly, DNA microarrays have provided the potential for screening the differential expression of transcripts of a large numbers of genes without a priori knowledge of their involvement in the particular function considered (Watson et al., 2000) . Secondly, in respect of the spatial analysis of gene expression, the application of in situ hybridization histochemistry or quantitative cell/tissue-speci®c PCR has permitted anatomical localization of gene expression. Combining these expression pattern and localization technologies has the potential to provide a detailed pro®le of the underlying genetic signature of any physiological or behavioural process. However, it is likely that making sense of the vast amount of data that could arise from the regional distribution of large numbers of genes will depend on future advances in information technology.
In addition to the search for links between behaviour and RNA pro®les, the genetic basis of neuroendocrine and behavioural traits can be traced by studying the genetic variability of natural and selectively-bred populations by identifying quantitative trait loci (QTL) and polymorphisms that contribute to a particular phenotype. Although the mammalian genetics still lacks the positional tools available to Drosophila geneticists, the sequencing of the genome has proved valuable for identifying candidate genes that may reside at loci identi®ed from QTL analyses. For example, recent genome-wide QTL analysis of two strains of mice that exhibit distinct phenotypes for aggression have identi®ed two loci associated with genes encoding diacylglycerol kinase a subunit and the glutamate receptor subunit AMPA3 (Brodkin et al., 2002) . Furthermore, by applying QTL analysis to a range of anxiety tests it has been possible to identify a signi®cant locus in the Roman High and Low avoidance rats (Fernandez-Teruel et al., 2002) . Analysis of polymorphisms within behaviourally relevant genes also offers the potential for determining the genetic basis of behavioural variability and neuropsychiatric disorders, with or without an a priori case for their involvement. For example, genetic linkage studies have implicated chromosome 21q22.3 in bipolar disorder which maps to a region encoding the ABCG1 gene (a homologueue of the Drosophila white gene that encodes a potential tryptophan transporter protein) where single nucleotide polymorphisms have been detected in samples from bipolar patients (Kirov et al., 2001) . Clearly, however, inherited susceptibility for most forms of psychopathology will probably result from multiple genes of small effect, so that linkages may be hard to establish. As with the study of RNA pro®les, advances in complex genetics may depend on the development of powerful informatics tools.
Analysis of genetically modi®ed animals, either by targeted null mutations or by random mutagenesis, has been extensively employed to examine how the modulation of speci®c genes alters speci®c behaviours and physiology. Some of the links between gene mutations and behaviour have proved surprisingly speci®c. For example, the crucial role of steroid hormones on lordosis has been shown by oestrogen receptor a knockout mice (Pfaff et al., 2002) and an oxytocin knockout mouse exhibits profound social amnesia without any other detectable cognitive de®cit (Ferguson et al., 2000) . However, there are a number of problems inherent in the use of knockout or transgenic animals for linking genes to behaviour. In particular, because genes are deleted during embryonic life, there may be marked developmental changes confounding the effect observed in adulthood. However, the advent of time-and spatially speci®c knockouts using`cre lox' bacterial DNA recombination system applied to the mammalian genome and tetracycline-inducible genes has begun to overcome these concerns. Gross et al. (2002) have, for example, engineered a conditional rescue strategy for serotonin 1A receptors selective to the forebrain or hindbrain and have been able to demonstrate that the presence of this receptor in the forebrain during postnatal development prevented the development of anxiety-like behaviour. Viral vectors are also extremely powerful tools to manipulate gene expression in speci®cally targeted groups of neurons. The use of these viruses not only allows the transfection of adult neurons or other cells which are not amenable to transfection by other strategies, but it permits experimental manipulation of gene expression in the brains of a variety of species. We, for example, have been able to use an adenovirus to transfect hypothalamic neurons with the vasopressin gene and functionally rescue the diuretic phenotype of the Brattleboro rat which arises from the single base deletion in the vasopressin gene (Geddes et al., 1997) . While this can be considered a signi®cant advance in the speci®city of transgenesis it should not be forgotten that the insertion of transgenes randomly within the genome still has the potential to disrupt other genes.
History and environment: important subsidiary subjects
At the same time as advances in genomic technology have helped establish a genetic basis for behavioural neuroendocrinology, it has become increasingly clear that neuroendocrine regulatory mechanisms are under the control of a variety of epigenetic factors, including environment and the programming effect of prior life history. In this respect genes are only the palette from which behaviour is painted, while the complex interactions with the environment and life events have the potential to generate a wider range of shades. Prior history has the ability to alter responses to subsequent stimuli not only through the cellular or systems level processes of learning and adaptation but also through programming of gene expression. This programming is especially evident during early life when developmental processes are not yet complete and subject to modulation. Although the processes through which early life in¯uences adult health and disease are not clearly understood, it is becoming apparent that early environment in¯uences the development of neuroendocrine systems [particularly the hypothalamic±pituitary±adrenal (HPA) axis] which, in turn, determine the physiology of an individual throughout their life span. Notably in recent years a considerable wealth of data has emerged on the programming effect of pre-and early postnatal stress on a wide range of neuroendocrine, physiological and behavioural processes (e.g. Seckl, 2001; Welberg & Seckl, 2001) . A common feature of this stress-related programming is activation of the HPA axis and the actions of glucocorticoids which are able to in¯uence the processes of cell development and the lifetime set-point of gene expression. Possibly for this reason, various physiological processes have evolved to protect the neonate from exposure to glucocorticoids, such as the presence of high concentrations of 11b-hydroxysteroid dehydrogenase in the placenta and the emergence of a stress hyporesponsive period during lactation in both the mother and neonate (Lightman et al., 2001) . However, these mechanisms are not perfect and early life adversity has been identi®ed as one of the main contributors to psychiatric illness and coronary heart disease, and may underlie other complex behaviours such as drug seeking or susceptibility to glucocorticoid-dependent autoimmune disease (Shanks et al., 2000) . Interestingly, because of the major parental contribution to the early neonatal environment, the interactions between parent and offspring provides a novel mechanism for nongenomic inheritance of these programmed effects. In this respect, recent studies have demonstrated that both the patterns of maternal behaviour and responsiveness to stress have a dependence on the quality and intensity of the mother±young interaction during the neonatal period, independent of the genetic background (Francis et al., 1999) . In these studies the level of maternal behaviour is stably transmitted between generations and cross-fostering studies show that the offspring inherit the behaviour from the nursing mother and not the biological mother. The neural basis of this intergenerational transmission appears to involve the central oxytocin system which, as already alluded to, determines many physiological and behavioural characteristics of motherhood (Champagne & Meaney, 2001 ). Thus, variations in the neural circuitry encoding maternal behaviour and the environmental demands on the mother combine to determine the quality of maternal care to her offspring which, in turn, programmes stress reactivity and maternal behaviour patterns in the offspring.
Finally, if any further layers of complexity are necessary, it is interesting to consider that the response to an environmental stimulus is itself dependent upon the genetic background on which it is imposed. Thus, it can be seen that early maternal stress will have one programming effect in one strain of rat and a different effect in another, and there are many examples of the way in which environmental stimuli (particularly those considered to be stressors) evoke quite different responses in different strains of animal. Moreover, environmental factors do not begin at birth. The most rapid period of neural development in placental mammals occurs in utero, when the complex interplay of maternal and offspring genomes can be biased by a range of environmental factors that have yet to be identi®ed.
New genomic avenues in behavioural neuroendocrinology 371
Small steps and giant leaps in the postgenome era Faced with the new wealth of genomic data and the potential for manipulating genes, what are the possibilities and limitations for determining the genomic basis of speci®c physiologies or patterns of behaviour? While it is clear that certain genes play a pre-eminent role in the genesis of particular behaviours and physiologies, and that the current environment and past history of an individual have major impact on expression patterns and programming, neither genes nor environment act alone in determining development and patterns of behaviour. An as yet little explored level of complexity comes from the interactions between the genetic and epigenetic mechanisms in determining gene expression. The future challenge is to de®ne the critical mechanisms through which the genetic constitution of an individual human or experimental animal interacts with environmental cues to result in altered physiological or even pathological behaviour and neuroendocrine function.
